4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cognition Therapeutics, Inc. (CGTX) operates in the Biotechnology industry and is headquartered in Purchase, United States with about 14 employees. Its market capitalization is roughly $85 million. In the fiscal year ended 2025-12-31, CGTX reported $0M in revenue and ($24M) in net income.
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($24M) | ($34M) | ($26M) | ($21M) | — |
| Net Income | ($24M) | ($34M) | ($26M) | ($21M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($5M) | ($4M) | ($5M) | ($7M) | ($9M) | — |
| Net Income | ($5M) | ($3M) | ($5M) | ($7M) | ($8M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $48M | $30M | $35M | $50M | — |
| Total Liabilities | $14M | $12M | $11M | $10M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CGTX viewer.
About TickerBase · Data methodology & sources